This website or its third-party tools process personal data. You can opt out of the sale of your personal information by clicking on the “Do Not Sell or Share My Personal Information” link.
Powered by
Opt-out Preferences
We use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. However, you can opt out of these cookies by checking "Do Not Sell or Share My Personal Information" and clicking the "Save My Preferences" button. Once you opt out, you can opt in again at any time by unchecking "Do Not Sell or Share My Personal Information" and clicking the "Save My Preferences" button.
Proventil-Hfa by Kindeva Drug Delivery Lp is an inhaler for asthma and COPD. It delivers albuterol sulfate, a bronchodilator, to relieve symptoms like wheezing and shortness of breath by relaxing airway muscles, improving breathing quickly and effectively.
Proventil-HFA, an inhaled beta-2 agonist, has moderate safety risks including side effects and drug interactions, requires careful use in special populations, and needs regular monitoring to ensure proper technique and prevent misuse or tolerance, aligning with FDA ACNU safety and usability standards.
ACNU Feasibility Scorecard
Chart with 11 data points.
Proventil-Hfa
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 2 to 5.
Safety & Risk ProfileSeverity of Side EffectsOverdose PotentialRisk of MisuseDrug-Drug InteractionsSpecial ConsiderationsUsability DifficultyDosing ComplexityMonitoring RequirementsAdherence DifficultyPotential for Tolerance